Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke

Phase 4

Completed

• Conditions: Cardiovascular Disease

• Registration Number: NCT00147602
• Lead Sponsor: Pfizer

Brief Summary

To determine whether Lipitor reduces stroke, compared to placebo in patients who have had a previous stroke or transient ischemic attack.

Detailed Description

Not available

Study Timeline

• Study Start: 1998-11
• Study First Submitted: 2005-09-06
• Study First Submitted QC: 2005-09-06
• Study First Posted: 2005-09-07
• Study Completion: 2005-11
• Status Verified: 2015-04
• Last Update Submitted: 2015-04-21
• Last Update Posted: 2015-04-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 4732

Inclusion Criteria

• Previous stroke or TIA

Exclusion Criteria

• coronary heart disease

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Time to occurrence of fatal or non-fatal stroke

Secondary Outcome Measures

Name	Time	Method
Time to occurrence of an acute coronary event, consisting of cardiac death, nonfatal myocardial infarction, resuscitated cardiac arrest or unstable angina.
Time to occurrence of a cerebrovascular event, defined as fatal or nonfatal stroke or TIA.

Trial Locations

Locations (1)

Pfizer Investigational Site; 🇻🇪 Caracas, Venezuela